Immunovia AB (publ) ( IMMNOV.ST) - Stock Earnings
IMMNOV.ST Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -29.7 million SEK | 101000 SEK |
| 2025Q4 | -17.3 million SEK | 354000 SEK |
| 2026Q1 | -18.4 million SEK | 374000 SEK |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
IMMNOV.ST Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -309.4 million SEK | 1.6 million SEK |
| 2024 | -76.5 million SEK | 931000 SEK |
| 2025 | -145.9 million SEK | 685000 SEK |
| 2026 Est. | — | — |
IMMNOV.ST
Price: SEK0.20
52 week price:
Earnings Per Share: -0.26 SEK
Exchange: STO
Sector: Healthcare
Industry: Diagnostics & Research
Market Capitalization: 127.3 million